Lee Ann Hawkins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lee Ann Hawkins has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Anthony Firek
2 shared publications- Helme Silvet
VA Loma Linda Healthcare System, Section of Cardiology, Loma Linda, CA 92357, USA
2 shared publications Shirley Kilian
2 shared publications- T. Michael Kashner
Department of Veterans Affairs, Office of Academic Affiliations, Washington, DC
2 shared publications Alan K. Jacobson
VA Loma Linda Healthcare System, Section of Cardiology, Loma Linda, CA
1 shared publicationBeth DeKoninck
1 shared publication
Latest Publications
- Open Access
- 21 January 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Cost-effectiveness of a pictorial medication sheet for older adults with heart failure and cognitive impairment
Background: Older adults with chronic health conditions like heart failure (HF) and cognitive impairment face challenges managing complex medication regimens, leading to poor adherence, worsening clinical status, and increased healthcare costs. Many existing interventions to improve medication adherence depend on digital technologies that may be too complex or require consistent caregiver support limiting their effectiveness in this population. Prior research demonstrated the efficacy of a simple pictorial medication sheet intervention compared to usual care. This study evaluates the cost-effectiveness of a pictorial medication sheet compared to usual care for older adults with HF and cognitive impairment. Methods: We developed a decision tree model with disease states in Microsoft Excel to evaluate changes in costs and quality-adjusted life years (QALYs) after implementing the intervention for older adults living with cognitive impairment and HF. The base case model used a one-year time horizon with adherence pathways and clinical outcomes, including decompensation, recovery, worsened or stable HF, and death. QALYs were calculated based on survival pathways and changes in health state utility. Costs included the intervention’s implementation and direct medical expenses related to HF care in the US. Sensitivity analyses (one-way, scenario, and Monte Carlo) explored how uncertainty in parameter inputs and time frame affects results. Results: Over a one-year time horizon, our model showed individuals using the pictorial medication sheet intervention had a total cost of $22,557 and 0.691 QALYs. Compared to usual care, the intervention was dominant (less costly and more effective), with $1,949 lower cost and a gain of 0.0045 QALYs, thus implementation for 100 individuals would potentially yield 0.45 QALYs and save $195,000 annually. Sensitivity analyses found that the intervention remained dominant over one year across plausible parameter ranges. A two-year analysis found that the intervention remained dominant across all tested scenarios, with QALY gains increasing almost six times more than the one-year model and cost savings ranged from $2,279 to $4,497 per patient. Conclusions: The pictorial medication sheet appeared to be cost saving and more effective than usual care for older adults living with cognitive impairment and HF in the United States. This finding supports evaluating strategies to implement the pictorial medication sheet at scale. Clinical trial number: Not applicable.
- 21 January 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open AccessCost-effectiveness of a pictorial medication sheet for older adults with heart failure and cognitive impairment
Background: Older adults with chronic health conditions like heart failure (HF) and cognitive impairment face challenges managing complex medication regimens, leading to poor adherence, worsening clinical status, and increased healthcare costs. Many existing interventions to improve medication adherence depend on digital technologies that may be too complex or require consistent caregiver support limiting their effectiveness in this population. Prior research demonstrated the efficacy of a simple pictorial medication sheet intervention compared to usual care. This study evaluates the cost-effectiveness of a pictorial medication sheet compared to usual care for older adults with HF and cognitive impairment. Methods: We developed a decision tree model with disease states in Microsoft Excel to evaluate changes in costs and quality-adjusted life years (QALYs) after implementing the intervention for older adults living with cognitive impairment and HF. The base case model used a one-year time horizon with adherence pathways and clinical outcomes, including decompensation, recovery, worsened or stable HF, and death. QALYs were calculated based on survival pathways and changes in health state utility. Costs included the intervention’s implementation and direct medical expenses related to HF care in the US. Sensitivity analyses (one-way, scenario, and Monte Carlo) explored how uncertainty in parameter inputs and time frame affects results. Results: Over a one-year time horizon, our model showed individuals using the pictorial medication sheet intervention had a total cost of $22,557 and 0.691 QALYs. Compared to usual care, the intervention was dominant (less costly and more effective), with $1,949 lower cost and a gain of 0.0045 QALYs, thus implementation for 100 individuals would potentially yield 0.45 QALYs and save $195,000 annually. Sensitivity analyses found that the intervention remained dominant over one year across plausible parameter ranges. A two-year analysis found that the intervention remained dominant across all tested scenarios, with QALY gains increasing almost six times more than the one-year model and cost savings ranged from $2,279 to $4,497 per patient. Conclusions: The pictorial medication sheet appeared to be cost saving and more effective than usual care for older adults living with cognitive impairment and HF in the United States. This finding supports evaluating strategies to implement the pictorial medication sheet at scale. Clinical trial number: Not applicable.
- 1 November 2018
- Published by Elsevier in Heart & Lung
- Vol. 47 (6) , 546-552
Cognitive impairment predicts mortality in outpatient veterans with heart failure
- 1 November 2018
- Published by Elsevier in Heart & Lung
- Vol. 47 (6) , 546-552
Cognitive impairment predicts mortality in outpatient veterans with heart failure
- 1 July 2017
- Published by Wolters Kluwer Health in Nurse Educator
- Vol. 42 (4) , 181-185
Learning Style as a Predictor of First-Time NCLEX-RN Success
Improving NCLEX-RN® pass rates remains a priority for nursing programs. Many programs collect learning style inventory data, yet few studies have looked at relationships between these data and NCLEX-RN pass/fail rates. Learning style preferences (visual, auditory, tactile, individual, group) and NCLEX pass/fail results were examined for 532 undergraduates in a Midwestern university. A significant correlation between preference for group learning and failure of the NCLEX was found (χ 2 = 5.99, P = .05).
- 1 July 2017
- Published by Wolters Kluwer Health in Nurse Educator
- Vol. 42 (4) , 181-185
Learning Style as a Predictor of First-Time NCLEX-RN Success
Improving NCLEX-RN® pass rates remains a priority for nursing programs. Many programs collect learning style inventory data, yet few studies have looked at relationships between these data and NCLEX-RN pass/fail rates. Learning style preferences (visual, auditory, tactile, individual, group) and NCLEX pass/fail results were examined for 532 undergraduates in a Midwestern university. A significant correlation between preference for group learning and failure of the NCLEX was found (χ 2 = 5.99, P = .05).
- 1 September 2016
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 12 (8) , 536-544
Spiritual Care Practices of Advanced Practice Nurses: A Multinational Study
- 1 September 2016
- Published by Elsevier in The Journal for Nurse Practitioners
- Vol. 12 (8) , 536-544
Spiritual Care Practices of Advanced Practice Nurses: A Multinational Study
- 1 November 2014
- Published by Elsevier in Heart & Lung
- Vol. 43 (6) , 486-493
Testing a novel pictorial medication sheet to improve adherence in veterans with heart failure and cognitive impairment
- 1 November 2014
- Published by Elsevier in Heart & Lung
- Vol. 43 (6) , 486-493
Testing a novel pictorial medication sheet to improve adherence in veterans with heart failure and cognitive impairment
- 1 March 2014
- Published by Elsevier in Heart & Lung
- Vol. 43 (2) , 168-169
Reply to letter to the Editor: Cognitive impairment and medication adherence in outpatients with heart failure
- 1 March 2014
- Published by Elsevier in Heart & Lung
- Vol. 43 (2) , 168-169
Reply to letter to the Editor: Cognitive impairment and medication adherence in outpatients with heart failure
- 1 November 2012
- Published by Elsevier in Heart & Lung
- Vol. 41 (6) , 572-582
Cognitive impairment and medication adherence in outpatients with heart failure
- 1 November 2012
- Published by Elsevier in Heart & Lung
- Vol. 41 (6) , 572-582
Cognitive impairment and medication adherence in outpatients with heart failure
- 9 September 2012
- Published by Wiley in Congestive Heart Failure
- Vol. 19 (1) , 25-28
Heart Rate Control in Patients With Chronic Atrial Fibrillation and Heart Failure
©2012 Wiley Periodicals, Inc.The goal of this study was to determine whether aggressive heart rate (HR) control in patients with both chronic atrial fibrillation (AF) and heart failure (HF) is associated with improved outcomes. HR control is one of the mainstays in management of patients with AF. However, rate control can be challenging in patients with HF. This study was designed as an interventional clinical trial, using patients with chronic AF and left ventricular systolic dysfunction with left ventricular ejection fraction ≤40% (n=20) as their own controls. Intervention consisted of increasing doses of metoprolol succinate to achieve target resting HR t test used to evaluate statistically significant change. After 3 months of intervention, average resting HR decreased from 94±14 beats per minute to 85±12 beats per minute. Average metoprolol succinate dose at the end of the study was 121 mg. None of the outcomes improved significantly after the intervention, including exercise tolerance (meters walked on 6‐minute walk test 326±83 vs 330±86), quality of life (Minnesota Living With Heart Failure Questionnaire score of 42.5±19 vs 38±21), and brain natriuretic peptide (242±306 pg/mL vs 279±395 pg/mL). Aggressive HR control was difficult in this group of patients with chronic AF and HF due to patient intolerance of increasing doses of β‐blockade, and not associated with improved outcomes. Further studies are needed to establish guidelines for target HR in patients with chronic AF who also have significant HF.
- 9 September 2012
- Published by Wiley in Congestive Heart Failure
- Vol. 19 (1) , 25-28
Heart Rate Control in Patients With Chronic Atrial Fibrillation and Heart Failure
©2012 Wiley Periodicals, Inc.The goal of this study was to determine whether aggressive heart rate (HR) control in patients with both chronic atrial fibrillation (AF) and heart failure (HF) is associated with improved outcomes. HR control is one of the mainstays in management of patients with AF. However, rate control can be challenging in patients with HF. This study was designed as an interventional clinical trial, using patients with chronic AF and left ventricular systolic dysfunction with left ventricular ejection fraction ≤40% (n=20) as their own controls. Intervention consisted of increasing doses of metoprolol succinate to achieve target resting HR t test used to evaluate statistically significant change. After 3 months of intervention, average resting HR decreased from 94±14 beats per minute to 85±12 beats per minute. Average metoprolol succinate dose at the end of the study was 121 mg. None of the outcomes improved significantly after the intervention, including exercise tolerance (meters walked on 6‐minute walk test 326±83 vs 330±86), quality of life (Minnesota Living With Heart Failure Questionnaire score of 42.5±19 vs 38±21), and brain natriuretic peptide (242±306 pg/mL vs 279±395 pg/mL). Aggressive HR control was difficult in this group of patients with chronic AF and HF due to patient intolerance of increasing doses of β‐blockade, and not associated with improved outcomes. Further studies are needed to establish guidelines for target HR in patients with chronic AF who also have significant HF.
- 31 August 2011
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 17 (8) , S5-S6
Is Cognitive Impairment Associated with Medication Adherence in Outpatients with Heart Failure?
- 31 August 2011
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 17 (8) , S5-S6
Is Cognitive Impairment Associated with Medication Adherence in Outpatients with Heart Failure?
- 1 September 2003
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 8 (3) , 187-192
Amiodarone Rescue Therapy for Severe Decompensated Heart Failure Initially Unsuitable for β-Blockers
Background: β-Blocker therapy is now standard therapy for patients with stable heart failure; however, fluid-overloaded, New York Heart Association Class IV patients tolerate β-blockers poorly. Amiodarone, a drug with antiadrenergic effects, has been shown to improve survival for patients with heart rates of 90 beats per minute or greater.
- 1 September 2003
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 8 (3) , 187-192
Amiodarone Rescue Therapy for Severe Decompensated Heart Failure Initially Unsuitable for β-Blockers
Background: β-Blocker therapy is now standard therapy for patients with stable heart failure; however, fluid-overloaded, New York Heart Association Class IV patients tolerate β-blockers poorly. Amiodarone, a drug with antiadrenergic effects, has been shown to improve survival for patients with heart rates of 90 beats per minute or greater.